[HTML][HTML] Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
M Pompsch, N Fisenkci, PA Horn, M Kraemer… - … Research and Practice, 2021 - Springer
Background Patients with multiple sclerosis receiving ocrelizumab-treatment are in
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis.
M Pompsch, N Fisenkci, PA Horn… - Neurological …, 2021 - europepmc.org
Background Patients with multiple sclerosis receiving ocrelizumab-treatment are in
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
[PDF][PDF] Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
M Pompsch, N Fisenkci, PA Horn, M Kraemer… - 2021 - scholar.archive.org
Background: Patients with multiple sclerosis receiving ocrelizumab-treatment are in
desperate need of a protection against SARS-CoV-2 infection. Methods: In this study …
desperate need of a protection against SARS-CoV-2 infection. Methods: In this study …
[HTML][HTML] Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
M Pompsch, N Fisenkci… - Neurological …, 2021 - neurolrespract.biomedcentral.com
Patients with multiple sclerosis receiving ocrelizumab-treatment are in desperate need of a
protection against SARS-CoV-2 infection. In this study, Euroimmun semi-quantitative Anti …
protection against SARS-CoV-2 infection. In this study, Euroimmun semi-quantitative Anti …
Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
P Mosche, F Neslinur, PA Horn… - Neurological …, 2021 - search.proquest.com
Background Patients with multiple sclerosis receiving ocrelizumab-treatment are in
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
[HTML][HTML] Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
M Pompsch, N Fisenkci, PA Horn… - Neurological …, 2021 - ncbi.nlm.nih.gov
Background Patients with multiple sclerosis receiving ocrelizumab-treatment are in
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
M Pompsch, N Fisenkci, PA Horn… - Neurological …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Patients with multiple sclerosis receiving ocrelizumab-treatment are in
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
[PDF][PDF] Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
M Pompsch, N Fisenkci, PA Horn, M Kraemer… - 2021 - scienceopen.com
Background: Patients with multiple sclerosis receiving ocrelizumab-treatment are in
desperate need of a protection against SARS-CoV-2 infection. Methods: In this study …
desperate need of a protection against SARS-CoV-2 infection. Methods: In this study …
Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis.
M Pompsch, N Fisenkci, PA Horn… - Neurological …, 2021 - europepmc.org
Background Patients with multiple sclerosis receiving ocrelizumab-treatment are in
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
desperate need of a protection against SARS-CoV-2 infection. Methods In this study …
[PDF][PDF] Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
M Pompsch, N Fisenkci, PA Horn, M Kraemer… - 2021 - neurolrespract.biomedcentral.com
Background: Patients with multiple sclerosis receiving ocrelizumab-treatment are in
desperate need of a protection against SARS-CoV-2 infection. Methods: In this study …
desperate need of a protection against SARS-CoV-2 infection. Methods: In this study …